Previous Article | Next Article 
Journal of Virology, October 1999, p. 8599-8611, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Initial Binding of Murine Leukemia Virus Particles
to Cells Does Not Require Specific Env-Receptor Interaction
Massimo
Pizzato,1,
Susan A.
Marlow,2
Edward D.
Blair,3 and
Yasuhiro
Takeuchi1,*
Chester Beatty Laboratories, Institute of
Cancer Research, London SW3 6JB,1
Polymasc Pharmaceuticals PLC, Royal Free Hospital, London
NW3 2EZ,2 and Virology Unit,
GlaxoWellcome, Medicines Research Centre, Stevenage SG1
2NY,3 United Kingdom
Received 12 November 1998/Accepted 10 June 1999
 |
ABSTRACT |
The initial step of virus-cell interaction was studied by
immunofluorescence microscopy. Single particles of murine leukemia virus (MLV) vectors and human immunodeficiency virus (HIV) were visualized by immunofluorescence. Fluorescent dots representing single
virions could be localized by staining of capsid proteins (CA) or
surface envelope proteins (SU) after fixation of virus supernatants.
This technique can be used to determine particle concentration in viral
supernatants and also to study virus-cell interaction. We investigated
the role of the Env-receptor interaction for the initial binding event
between the cell and the viral particles. Ecotropic MLV vector
particles were shown to bind to human cells which do not express the
specific viral receptor. In addition, MLV particles defective for Env
were shown to bind the cells similarly to infectious MLV. Time course
experiments of virus-cell binding and dissociation showed identical
profiles for infectious and Env-defective MLV particles and suggested
that MLV Env is not involved in the early phases of attachment of virus
to cells. The possible implication of cellular factors in enhancing
viral binding and infectivity is discussed.
 |
INTRODUCTION |
Understanding of the mechanism by
which retroviral particles infect target cells is useful both for the
development of antiretroviral therapies and for the improvement of
retroviral vectors. Virus-cell binding, virus entry, and subsequent
trafficking of human immunodeficiency virus (HIV) and murine leukemia
virus (MLV) particles have been actively studied, mainly by genetic
approaches, by biochemical methods, or by fluorescence-activated cell
sorter (FACS) analysis of individual target cells. For example, cell
surface receptors for retroviruses have been identified and
characterized by genetic approaches of DNA transfection and pseudotype
infection and Env-mediated fusion assays (42). Specific
binding of virus Env and its receptor can be studied by binding assays
with Env labeled with radioisotopes (12, 18, 21) or antibody
staining followed by FACS analyses (19). Trafficking of
retroviruses in target cells has been studied mainly by localization of
virus components by fractionation of subcellular compartments or
microscopic observation of fluorescence-labeled proteins rather than
virus particles (17, 23). While these approaches provide
important information for the understanding of virus-cell interactions,
microscopic visualization of single retrovirus particles in the process
of infection would represent a powerful approach to directly observe
initial events in virus infection.
Observation of single retrovirus particles has thus far been limited to
electron microscopy (EM) techniques. EM has been used to count virus
particles (45), to study virus morphology and the process of
virus budding from producer cells, and occasionally to study virus-cell
binding (33). However, relatively little information on
retrovirus particle-cell interaction in the infection process has been
obtained by EM techniques. Recent developments in fluorescence
microscopy have raised interest in the visualization of single virus
particles. Although many researchers considered that most viruses would
be too small to detect by optical microscopy because of its limited
resolution (250 nm), visualization of single particles of adenovirus,
adeno-associated virus, and vaccinia virus by immunofluorescence
microscopy has recently been reported. Nonenveloped adenovirus and
adeno-associated virus have been chemically labeled with cyanine-based
fluorophores, and their binding and entry into cells have been examined
(4, 22). By directly conjugating fluorophores to the virus,
there is no complication of antibody accessibility and infection can be
analyzed in living cells and tissues. However, this method is unlikely
to be feasible for many enveloped viruses, including retroviruses,
which are more fragile and difficult to purify than adenovirus and
adeno-associated virus. Binding of the enveloped vaccinia virus
(approximately 250 to 350 nm in diameter) to cells was studied by
confocal microscopy after indirect immunostaining of virus antigen in
fixed samples (40). Individual vaccinia virus virions
appeared as clear fluorescent spots, and it was suggested that the
method may be applicable to viruses as small as 50 nm.
In this study, we have established a method to visualize single
retrovirus particles by indirect immunostaining. By using this method,
virus particles were enumerated and unexpected binding of noninfectious
MLV vector particles to cells was observed.
 |
MATERIALS AND METHODS |
Cells and viruses.
TE671 (ATCC CRL8805), A431 (ATCC
CRL-1555), NIH 3T3, and all packaging cell lines were grown in
Dulbecco's modified Eagle's medium. Human umbilical vein endothelial
cell (HUVEC) (HUV-EC-C CRL-1730) cultures were grown in endothelial
growth medium (EGM-MV; TCS Clonetics Corp.). Igrov-1 (provided by M. Ford), CEM (ATCC CCL 119), Raji (ATCC CCL-86), U937 (ATCC CRL-1593.2),
and H9 (ATCC HTB-176) cells were cultured in RPMI 1640 medium. Growth
media were supplemented with 10% (vol/vol) heat-inactivated fetal calf serum, penicillin G (100 U/ml), and streptomycin (100 mg/ml), and cell
cultures were maintained at 37°C under 5% CO2. TELCeB6, TELCeB6/AF7, and TELCeB6/MOF are helper-free packaging cells producing MLV-based retrovirus vector particles which carry the MFGnlslacZ genome and bear no envelope, 4070A amphotropic MLV envelope, and ecotropic Moloney MLV envelope glycoproteins, respectively (10, 24). The HIV-1(GUN-1) isolate (37) was produced by
chronically infected H9 cells. Virus particles were harvested after
cocultivation with fresh H9 cells for 3 days. Virus stocks were snap
frozen and stored in liquid nitrogen. Viral supernatants were filtered through 450-nm-pore-size filters (Sartorius) before use.
Antibodies.
Goat polyclonal antibodies (Quality Biotech
Inc.) were used to detect MLV capsid proteins (anti-RLV p30) and MLV
surface envelope proteins (SU) (anti-RLV gp69/71). A rat monoclonal
immunoglobulin G (IgG) antibody, 83A25, which recognizes MLV SU was
kindly provided by L. H. Evans (13). A mouse monoclonal
anti-HIV-1 p24 IgG antibody EVA365 (AIDS reagents, MRC program) and a
rat monoclonal IgG antibody against the HIV-1(GUN-1) gp120 V3-loop, Aw
(26), were used to stain HIV-1 virions. Fluorescein
isothiocyanate (FITC)-conjugated donkey IgG against goat IgG (Jackson),
FITC-conjugated rabbit IgG against mouse IgG (Dako), and Texas
red-conjugated donkey IgG against rat IgG (Jackson) were used as
secondary antibodies. For immunoelectron microscopy, 10-nm-gold
particle-conjugated goat IgG against fluorescein (British Biocell
International) was used as the tertiary antibody.
Immunofluorescent staining of viral particles.
Two methods
of fixing virus particles onto glass slides or coverslips (BDH) were
examined. Virus suspensions (5-µl volumes) were spread and air dried
on a 1-cm2 area of glass slide and fixed with 4%
paraformaldehyde for 15 min at room temperature. Alternatively, 50 µl
of viral supernatants was incubated on glass slides for 1 h at
37°C in the presence of 8µg of Polybrene (Sigma) per ml. This
method follows our observation that Polybrene promotes the adhesion of
virus particles to plastic and glass surfaces. Fixed virus particles
were permeabilized with 0.2% Triton X-100 for 15 min at room
temperature and then washed three times with phosphate-buffered saline
(PBS). Virus samples were incubated with anti-Rauscher leukemia virus
p30 and 83A25 (MLV samples) or anti-HIV-1 p24 and anti-HIV-1 gp120 (HIV
samples) primary antibodies for 45 min at room temperature, washed
three times with PBS, and incubated with the appropriate secondary
antibodies for 45 min at room temperature. After being washed three
times with PBS, the slides were mounted with immunofluorescence
mounting medium (Dako) and observed by confocal microscopy (MRC 1024 [Bio-Rad] equipped with a krypton-argon laser). All pictures were
acquired by using Kalman filtration and analyzed with Lasersharp
software (Bio-Rad).
Estimation of particle size, infectious titer, and physical
number of MLV vectors.
A LacZ(MLV-A) vector was harvested from
TELCeB6/AF7 and sequentially passed through syringe filters with the
following pore sizes: 450 nm (Sartorius), 200 nm (Sartorius), 100 nm
(Millipore), and 20 nm (Millipore). After each filtration, aliquots of
filtrates were examined by titer determination for LacZ infection on
TE671 cells as described previously (36) and by virus
particle immunostaining. To determine the physical virus particle
number, 110-nm-diameter red fluorescent carboxylate-modified
microspheres (FluoSpheres; Molecular Probes) were added to the
filtrates at a final concentration of 2.7 × 108
microspheres/ml. Alternatively, the same concentration of microspheres was added to the viral supernatant before filtration, in order to
confirm the retention capacity of the filters. Mixtures of virus
particles and fluorescent microspheres were immobilized on glass slides
and processed for immunostaining as described above. The virus particle
number in the vector preparation was calculated as the product of the
microsphere concentration and the ratio of counts of fluorescent dots
for virus and microsphere particles on the assumption that viral
particles and microspheres were immobilized and fixed with similar
efficiency, as suggested by the following observations.
Microsphere-virus particle ratios were similar when the two different
methods described were used to immobilize virions and microspheres or
when a 50:50 mixture of acetone and methanol was used instead of
paraformaldehyde to fix the samples. In addition, a similar ratio was
found when the same mixture was immobilized and fixed on nickel grids
and analyzed by EM (see below).
EM.
To directly compare our immunofluorescence method with
EM, a mixture of viral supernatant and microspheres was immobilized on
coated nickel grids by the same procedure used for immobilization on
glass slides. The mixture of virus and beads was incubated for 1 h
at 37°C in the presence of 8 µg of Polybrene per ml. Alternatively 200 µl of virus-bead mixture was ultracentrifuged onto nickel grids
at 100,000 × g for 10 min in an EM-90 rotor (Beckman
Airfuge) by the method described by Zheng et al. (45).
Specimens were then fixed on grids with 4% paraformaldehyde in PBS for
15 min at room temperature and permeabilized by treatment with 0.2%
Triton X for 15 min at room temperature. After 10 min of blocking
treatment with 0.1% bovine serum albumin (Sigma) and 0.1% fish
gelatin in Tris-buffered saline (TBS; pH 8.2), capsid immunostaining
was performed by incubation with anti-RLV p30 for 45 min at room
temperature. After being washed three times with TBS, the grids were
incubated with FITC-conjugated anti-goat antibody for 45 min at room
temperature, washed three times in TBS, and incubated with gold-labeled
anti-FITC antibody for 45 min at room temperature. After three washes
in TBS and one wash in water, the grids were negatively stained for 2 min in 2% aqueous uranyl acetate or 3% phosphotungstic acid (PTA).
The virus particles were immunolabeled with gold-conjugated antibodies
to accurately differentiate virus particles from negatively stained
cellular debris. The grids were observed with a IL20 Philips transmission electron microscope. The ratio between viral particles and
beads was determined by the number of virions found during the counting
of 500 beads on duplicate grids. Viral particle number was estimated by
multiplying the bead/virion ratio by the concentration of beads in the
mixture analyzed.
Virus-cell microscopy binding assay.
Cells were seeded onto
13-mm glass coverslips in a 24-well plate at 5 × 104
cells/well. After overnight incubation, 0.5 ml of viral suspensions, containing about 4 × 108 physical virus particles/ml,
were added for 1 h at 37°C. The cells were then washed five
times with PBS supplemented with 1 mM MgCl2 and 1 mM
CaCl2 to prevent cell detachment from the glass surface.
The cells were fixed with acetone-methanol (1:1) for 3 min at 4°C.
The cell monolayer was air dried and rinsed with PBS. Alternatively,
coverslips were fixed with 4% paraformaldehyde for 15 min at room
temperature and permeabilized with 0.2% Triton X for 15 min at room
temperature. The samples were then blocked with a 1% solution of
bovine serum albumin in PBS for 15 min, washed with PBS, and incubated
with primary antibodies for 45 min at room temperature. The coverslips
were washed three times with PBS, incubated with secondary antibodies
for 45 min at room temperature, and extensively washed with PBS. After
a final wash with distilled water, the coverslips were mounted with
immunofluorescence mounting medium (Dako) and analyzed by confocal microscopy.
To study virus binding to cells in suspension, adherent cells were
harvested as a suspension by using 10 mM EDTA solution in PBS. Then
106 cells were incubated with 1 ml of virus suspension for
1 h at 37°C. After the cells were washed three times in PBS,
each sample was resuspended in 50 µl of PBS, fixed with 250 µl of
acetone-methanol (1:1) for 3 min, and centrifuged onto 13-mm coverslips
in 24-well plates. After a further wash with PBS, the coverslips were
processed for immunostaining as described above.
Alternatively, cells in suspension were fixed with a 4% solution of
paraformaldehyde for 15 min at room temperature, permeabilized with
0.2% Triton X for 15 min, and processed for immunostaining in
suspension. The cells were then concentrated by centrifugation, resuspended in 10 µl of mounting medium, and mounted on glass microscope slides.
FACS analysis.
Cells were washed in PBS and detached with 10 mM EDTA in PBS. Then 106 cells were incubated with 1 ml of
virus suspensions for 1 h at 37°C, washed three times with
ice-cold PBS, and fixed with 4% paraformaldehyde in PBS for 15 min at
room temperature. For p30 staining, cells and virions were also
permeabilized with 0.2% Triton X in PBS for 15 min. The cells were
washed extensively in PBS, incubated with primary antibody, washed
three times with PBS, and incubated with the secondary antibody for 45 min at room temperature. After a final wash, samples were subjected to
FACScan (Becton-Dickinson) analysis. The same samples were also
processed for analysis by confocal microscopy as described above.
 |
RESULTS |
Visualization of retrovirus particles.
To test if retrovirus
particles could be visualized by immunostaining, MLV vector particles
were immobilized on glass slides by drying the viral supernatant onto
the slide surface or by incubation at 37°C in the presence of 8 µg
of Polybrene per ml. Immobilized virions were fixed with
paraformaldehyde and permeabilized with Triton X. Double staining was
then performed with anti-CA and anti-Env antibodies followed by FITC-
and Texas red-labeled secondary antibodies, respectively. Doubly
stained spots were observed for MLV vectors bearing MLV-A Env proteins
(Fig. 1, MLV ampho), while noninfectious
MLV vectors, devoid of Env proteins, produced spots stained with
anti-CA but not anti-Env antibodies (Fig. 1, MLV no Env). As a negative
control, no spots were observed for supernatants harvested from TEL
cells which do not contain MLV structural genes (data not shown). These
results demonstrated that complexes, which contain both MLV CA and Env,
can be specifically detected in the supernatant from packaging cells
producing infectious MLV vectors. Figure 1 also shows that similar
complexes containing both CA and Env for HIV-1 can be visualized with
anti-HIV antibodies. The specificity of staining was further
demonstrated by staining different HIV-1 strains with strain-specific
anti-Env antibodies and that anti-HIV antibodies do not stain MLV
particles and vice versa (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Visualization of MLV vector and HIV-1 particles. Virus
supernatants of MLV vectors bearing MLV-A Env (ampho) and no Env and
HIV-1 GUN-1 isolate were air dried and fixed with 4% paraformaldehyde
on glass slides. After permeabilization, immunostaining was performed
with anti-CA antibodies followed by FITC-labeled secondary antibodies
(anti-CA) and with anti-SU antibodies followed by Texas red-labeled
secondary antibodies (anti-SU). Images for green and red fluorescence
were acquired separately and overlaid (merged). Bar, 2 µm.
|
|
To examine if the above-stained spots represent single virus particles,
their size was estimated by their removal following filtration through
different pore sizes. Virus supernatant was mixed with a known
concentration of 110-nm-diameter fluorescent microspheres, filtered,
and then processed for capsid immunostaining (Fig.
2, top panels). No removal of
immunostained spots or fluorescent microspheres was observed after
filtration through the 200-nm-pore-size filter, while removal was
significant and similar for both fluorescent microspheres and
immunostained particles following filtration through the 100- and
20-nm-pore-size filters (Fig. 2, top panels). To accurately estimate
the number of immunostained spots remaining after filtration, a
constant concentration of fluorescent microspheres was added after
filtration of the supernatant (Fig. 2, bottom panels). The ratio
between immunostained spots and microspheres was determined. No removal
of immunostained complexes was observed after filtration through the
200-nm-pore-size filter, while filtration through the 100- and
20-nm-pore-size filters resulted in about 70% and more than 99%
removal, respectively (Fig. 2, bottom panels). LacZ infectious titer
was also similarly removed by filtration (Fig. 2). These results
indicate that the sizes of immunostained complexes and infectious LacZ
vectors were between 20 and 200 nm, consistent with the reported size
of retrovirus particles as estimated by EM (see Fig. 3) (15,
29). We therefore conclude that the immunofluorescent spots,
which stained positively for both CA and Env proteins and were about
100 nm in diameter, represent single retrovirus particles.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Estimation of size and physical number of MLV particles.
A LacZ(MLV) supernatant was filtered through 450-, 200-, 100-, and
20-nm-pore-size filters in succession. Red-fluorescent microspheres
were added to the supernatant before filtration (top panels) or after
filtration (bottom panels) at 2.7 × 108/ml and
processed for immunostaining for MLV CA proteins as in Fig. 1. Stained
viral particles and fluorescent microspheres from the sample filtered
before microsphere addition (bottom panel) were counted in five random
fields of 5,500 µm2, and the microsphere/viral particle
ratio was measured. Results are expressed as mean values of the
estimated ratios ± standard errors of the mean. LacZ titer was
measured on TE671 cells. Bar, 2 µm. n.d., not determined.
|
|
Physical counting of virus particles.
We investigated the use
of immunofluorescence microscopy as alternative method to estimate the
physical number of retrovirus particles. Such a method would be much
less time-consuming and less labor-intensive than EM techniques and
could be used routinely. We therefore added a known concentration of
fluorescent microspheres (final concentration, 2.7 × 108 microspheres/ml) to virus suspensions and processed the
samples as for immunofluorescence observations as described above. The virus particle number was estimated from the ratio between
immunostained virus particles and fluorescent microspheres. By this
method, the physical particle concentration of the sample in the above experiment was estimated to be about 7 × 108/ml (Fig.
2). To test the reliability of this counting method, a
virus-microsphere mixture was quantified by transmission electron microscopy and immunofluorescence in parallel. By using the same procedure as for immunofluorescence microscopy, microspheres and virus
were immobilized onto EM grids and processed for capsid immunostaining.
Specimens on EM grids were additionally treated with gold-labeled
anti-FITC antibody and negatively stained with uranyl acetate or PTA.
The viral particle number calculated from the microsphere/virus ratio
was 0.34 × 109 particles/ml when viral particles were
immobilized to the grid by incubation with Polybrene and 1.42 × 109 particles/ml when viral particles were immobilized by
the ultracentrifugation method. The same viral suspension was
estimated to contain 1.25 × 109 particles per ml by
immunofluorescence. This result confirmed the reliability of
immunofluorescence as method for the quantification of viral particles
in an MLV suspension. Transmission electron microscopy observations
also confirmed that viral particles and microspheres are of similar
size (100 to 120 nm in diameter) and do not form aggregates during the
fixation step (Fig. 3).

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 3.
Negative staining and immuno-EM of viral particles. A
mixture of virus particles and beads was adsorbed to an EM nickel grid
by ultracentrifugation (A) or by a 1-h incubation at 37°C in the
presence of 8 µg of Polybrene per ml (B). Samples were then processed
for capsid immunostaining and negative staining with PTA (A) or uranyl
acetate (B). The beads measure 110 nm in diameter. Bar, 100 nm.
|
|
As shown in Fig. 2, a LacZ(MLV-A) preparation of about 7 × 108 physical particles/ml contained about 2 × 106 LacZ infectious units/ml. Therefore, the infectious
unit/physical particle number ratio was estimated to be 3 × 10
3. This is in agreement with previous estimations that
the infectious titer is only a small fraction of the physical
retrovirus particle number (20, 35, 44).
Virus particle binding to the cell surface is independent of
specific Env-receptor interaction.
Virus particles bound to the
cell surface were visualized by immunostaining to study virion-cell
interaction. Human TE671 cells, which express the receptor for MLV-A
but not for MLV-E, were grown on glass coverslips and incubated with
viral supernatants. Virus particles attached to the cells were stained
after fixation and permeabilization. Figure
4 shows immunofluorescence staining with
anti-CA antibody. Fluorescent spots were detected on cells incubated
with LacZ(MLV-A) (Fig. 4A) but not on cells incubated with a control
cell supernatant containing no virus (Fig. 4D). Analysis of sequential
optical sections of the specimen indicated that the great majority of
viral particles were located on the cell surface (data not shown).
Similar viral binding was observed under conditions preventing capping
and endocytosis, such as at 4°C or in the presence of sodium azide
(data not shown). This suggests that the observed dots represented
single virions rather than aggregates formed by capping after membrane
binding.

View larger version (113K):
[in this window]
[in a new window]
|
FIG. 4.
Binding of MLV vector particles to TE671 cells. Cell
supernatant of TE671 cells producing LacZ(MLV-A) (A), LacZ(MLV-E) (B),
LacZ pseudotype without Env proteins (C), and no virus particle (D) was
added to TE671 cells. The cells were washed extensively after a 1-h
incubation and then fixed with acetone-methanol (1:1). Samples were
stained for MLV CA proteins with FITC-labeled secondary antibodies.
Bar, 5 µm.
|
|
Surprisingly, LacZ pseudotypes bearing ecotropic MLV Env (Fig. 4B) or
no Env (Fig. 4C) bound to TE671 cells at similar levels to LacZ(MLV-A)
despite the fact that they cannot infect TE671 cells. LacZ(MLV-A) and
LacZ(MLV-E) but not Env-defective pseudotypes could also be stained
with anti-Env on TE671 cells in double-staining experiments (data not
shown). These experiments show the ability of MLV particles to bind to
the cell surface in the absence of the specific viral receptor, as
shown by LacZ(MLV-E) binding to human cells, or in the absence of viral
glycoprotein, as shown by Env-defective virus binding. As shown later
(see Fig. 8), this phenomenon is not peculiar to TE671 cells.
Furthermore, LacZ(MLV-E) particles produced from a murine packaging
cell line also bound efficiently to TE671 cells, which are resistant to
MLV-E infection (data not shown). These results indicate that the
virion-cell binding is independent of specific receptor-Env interaction
and is not peculiar to the initial pair of virus producer and target cell types tested.
Comparison of virus binding assays by FACS and microscopy
analyses.
A standard method used to study virus-cell binding is
FACS analysis of cells which are incubated with virus supernatants and then subjected to surface staining with anti-Env antibodies. In this
assay, positive fluorescence shifts represent specific receptor-Env interactions and no shift has been observed in the absence of cognate
receptors and Env, such as the case of MLV-E with receptor-negative human cells (19). The observations in our microscopy study, showing that retrovirus particles bind to cells in the absence of
specific receptor-Env interaction, appear to contradict the results of
the FACS analyses. Therefore, we directly compared FACS and microscopy
analyses of virus-cell binding. Suspensions of TE671 cells were
incubated with amphotropic, ecotropic, and Env-defective viruses and
control supernatant. After fixation, cells were processed for CA
staining or for Env staining. The same samples were then analyzed by
both FACS and confocal microscopy. Figure
5 shows micrographs of anti-CA and
anti-Env (SU) staining and FACS histograms of anti-Env staining. FACS
analysis of anti-CA staining showed only minimal shifts for all three
viruses (data not shown), consistent with the microscopy observation,
which showed binding of similar numbers of virus particles for
amphotropic, ecotropic, and Env-defective viruses (Fig. 5). Following
SU staining, a significant shift by FACS was detected only with
amphotropic virus, while confocal microscopy also detected the presence
of virus particles on cells which had been incubated with MLV-E. However, cells incubated with amphotropic virus, but not ecotropic virus, demonstrated a diffuse surface staining following anti-SU staining, in addition to brighter spots of fluorescence, while CA
staining produced only bright spots. Such diffuse fluorescence is
likely to be caused by specific binding of soluble SU proteins present
in virus supernatants to their receptors (8, 25, 43) and
results in significant shifts during FACS analyses. These results
suggest that, although FACS analysis can efficiently detect the
specific Env-receptor interaction, it reflects soluble SU binding
rather than virus particle binding.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 5.
Comparison of FACS and confocal microscopy analyses of
MLV vector binding to TE671 cells. Suspended TE671 cells were incubated
with supernatants of TE671 cells producing LacZ(MLV-A) (ampho),
LacZ(MLV-E) (eco), LacZ pseudotype without Env proteins (no Env), and
no virus particle (no virus) for 1 h, washed, and then fixed with
4% paraformaldehyde. The cells were stained with either anti-MLV CA
(anti-CA) antibodies after permeabilization or anti-MLV SU antibodies
without permeabilization. The micrographs are projected optical
sections performed every 1 µm perpendicular to the z axis
throughout the sample. Bar, 5 µm. Histograms of cells incubated with
vector particles are shaded and shown together with histograms of cells
incubated with virus-free cell supernatant (white).
|
|
Kinetics of virion binding to cells.
The kinetics of virus
binding to TE671 cells in the presence and absence of specific
receptor-Env interaction was compared. The virus-cell association rate
was examined by incubating target cells with amphotropic or
Env-defective virus suspensions for variable times at 37°C and then
staining them for CA (Fig. 6). When both
viruses were used, bound virions could be detected after only 1 min and
the maximum number of virions was detected after a 30-min incubation.
No increase in the number of bound viruses was detected beyond 30 min
(60 and 120 min [data not shown]). It has been reported that the
large majority of viral particles added to cell cultures may not meet
the target cells because their movement is restricted by Brownian
motion (7). There is no method yet to directly measure the
rate of collision between the virus particle and the cell. However, we
calculated a theoretical number of virions that would collide with a
single cell during 60 min under our experimental conditions as 100, according to previously described formulae (27). It is
likely that a large proportion of virions stably bind to the cell
surface when they collide with the cell, because more than 30 fluorescent spots were visualized on a single cell after a 60-min
incubation. No quantitative difference was detected at any time point
between virions with and without Env (Fig. 6). Similar kinetics of
virus attachment to TE671 cells was also observed at 4°C for both
amphotropic and Env-defective viruses (data not shown). These results
suggested that the rate of virion attachment to the cell surface is
similar in the presence and absence of specific receptor-Env
interaction and that such attachment is mediated by components on virus
and cell surfaces other than viral Env and its cognate receptor.

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 6.
Kinetics of binding of MLV vector particles to adherent
cells. TE671 cells were incubated with MLV vector particles with MLV-A
Env (ampho) and without any Env protein (no Env) for 1, 5, 15, and 30 min and then processed for immunostaining with anti-MLV CA antibodies
followed by FITC-labeled secondary antibodies. Bar, 5 µm.
|
|
The virus-cell dissociation rate was then analyzed in two ways. First,
adherent TE671 cells incubated with vector particles were washed and
kept at 37°C in the normal medium supplemented with 0.1% sodium
azide in order to prevent particle internalization. Second, suspensions
of TE671 cells were incubated with amphotropic and Env-defective virus
at 37°C. After 60 min, the cells were washed and kept in PBS at
4°C. The number of viral particles bound to the cell surface after
different times (from 1 to 120 min) was detected. Similar numbers of
virions were detected on cells incubated with amphotropic or
Env-defective viruses at each time point analyzed (Fig.
7). The number of virus particles
decreased by about 10 and 70% at 4 and 37°C, respectively.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 7.
Kinetics of MLV vector particles dissociation from
cells. TE671 cells were incubated with MLV vector particles with MLV-A
Env (ampho) and without any Env protein (no Env). After 1 h, the
cells were washed and kept in fresh medium at 37°C and 0.1% sodium
azide (A) or in PBS at 4°C (B) for the indicated time. Samples were
then processed for capsid immunostaining. The micrographs are projected
optical sections performed every 1 µm. Bar, 5 µm.
|
|
Inefficient Env-independent binding on suspension cell lines.
Viral binding of virus particles with or without Env proteins was
studied on several cell lines. Adherent cell types, including murine
NIH 3T3 fibroblasts, human epithelial A431 cells, human ovarian Igrov-1
cells, human endothelial HUVEC (Fig. 8)
and human microvasculature endothelial cells (HMEC) cells, and human
glioblastoma NP2 cells (data not shown) were analyzed as described
above. The levels of binding of amphotropic and Env-defective MLV were
similar on each cell line tested, suggesting that many adherent cell
lines have the ability to adsorb virus particles in an
Env-receptor-independent manner, albeit at somewhat different levels
(Fig. 8). In contrast, poor virus binding was detected on several cell
lines growing in suspension. A viral binding assay for cells in
suspension was performed with the human T-cell lines CEM and Jurkat;
B-cell lines Namalwa, DG75, and Raji; monocytic cell line U937; and
adherent cells suspended by EDTA treatment. Cells in suspension were
incubated with MLV vectors with or without MLV-A Env and then stained
with anti-CA antibodies. Efficient virus particle binding, for both enveloped and nonenveloped vectors, was shown for TE671 cells (Fig.
9) and the other suspensions of adherent
cells analyzed (data not shown). In contrast, only small numbers of
fluorescent spots were detected on the suspension cell lines (CEM,
U937, and Raji [Fig. 9], and DG75, Jurkat, and Namalwa [data not
shown]). These results indicate that some cell types lack the ability
to efficiently adsorb MLV particles in an Env-receptor-independent way.

View larger version (118K):
[in this window]
[in a new window]
|
FIG. 8.
Binding of MLV vector particles to different adherent
cells. Cell cultures were incubated with MLV-A (ampho), MLV Env
defective (no Env), or mock viral supernatants (no virus). After a 1-h
incubation, the cells were washed, fixed, permeabilized, and stained
for capsid proteins. Bar, 5 µm.
|
|

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 9.
Binding of MLV vector particles and MLV-A Env to
suspension cells. Adherent TE671 cells harvested with EDTA and three
suspension cultures were incubated with MLV-A particles (ampho), MLV
Env-defective particles (no Env), or mock supernatant (no virus). (A)
Microscopy analyses. Cells were permeabilized and stained for MLV-CA.
Bar, 10 µm. (B) FACS analysis. Cells were stained for SU and analyzed
by FACS. White and black histograms show samples incubated with
Env-defective and MLV-A supernatants, respectively. Micrographs are
projected optical sections performed every 0.5 µm.
|
|
We also noticed that LacZ(MLV-A) infected all suspension cells tested
much less efficiently than it infected adherent cells, such as TE671
and NIH 3T3 cells; LacZ titers on suspension cells were typically
between 100- and 1,000-fold lower than those on TE671 cells. This
observation may suggest that Env-receptor-independent binding is
significant in the process of MLV infection.
Like our observation on TE671 cells described above (Fig. 5), we
noticed a discrepancy between FACS and microscopy analyses of MLV-A
particle binding to suspension cells. Suspension cultures, including
detached TE671, were incubated with amphotropic and Env-defective viral
supernatants, processed for Env staining, and subjected to FACS
analysis (Fig. 9B). Significant and similar fluorescent shifts were
obtained when cells were incubated with MLV-A supernatants, indicating
that a similar amount of Env SU binds the cell surface of all cell
types. Therefore, this result suggests that the viral receptor is
similarly expressed and that a difference in viral infectivity and
virus particle binding for adherent and suspension cells cannot be
explained by different levels of the virus receptor expression.
 |
DISCUSSION |
Image analysis of single retrovirus particles has so far been
limited to TEM studies. In this study, we show that retrovirus particles can be visualized as fluorescent spots following indirect immunofluorescent staining. Viral particles could be stained for both a
virus core protein, CA, and a virus envelope protein, SU. By using
filters with different pore sizes to retain the particles, we estimated
that the diameters of the visualized spots were less than 200 nm but
that the particles were largely retained by 100-nm-pore-size filters.
TEM observation of the same virus preparations confirmed that the
visualized particles were single virions of about 100 nm in diameter.
A method to count physical number of virus particles was developed by
adding a known concentration of fluorescent microspheres to virus
samples to act as internal controls. The virus particle concentration
could be calculated from the ratio of virus particles and microspheres
measured by fluorescence microscopy. The reliability of this method was
confirmed by direct comparison with a TEM-based counting method
(45). The advantage of immunofluorescence over TEM methods
is that sample processing and analysis is much easier and less
time-consuming. Therefore, we think that this technique will be useful
in any experiment which requires virus quantification, such as
screening for packaging cell lines that efficiently produce retrovirus
vectors, monitoring the level of virus concentration during virus
purification and concentration, and quantifying virus particle
contamination of biological products.
The ratio of infectious units to particle number estimated by our
immunostaining method was about 3 × 10
3. This
result is in agreement with previous reports that the infectious titer
is only a small fraction of the physical retrovirus particle number
(20, 35, 44). A major reason for such a low infectious titer
compared with the physical number of particles may be the rate of
particle collision with the cell surface. It has been reported that the
large majority of viral particles plated on cells may not meet the
target cells because their movement is restricted by Brownian motion
(1-3, 6, 7). Indeed, little or no reduction in infectivity
was recorded when a virus inoculum recovered from the first round
infection was plated on fresh cells in the second round (38,
41). One additional possibility is that not all the virus
particles are fully functional, but to date it is impossible to examine
the function and the stoichiometric composition of individual virus
particles. It is noteworthy that more than 90% of the spots for both
MLV vectors and HIV were costained for CA and SU and significant
numbers of virus particles devoid of Env, which were previously
hypothesized to result from inefficient Env incorporation and Env
shedding (25, 43), were not detected (Fig. 1). Another
possibility is that fully functional virus particles are guided to
noninfectious pathways in some circumstances (8, 23) or are
lost at various steps in the infection process.
Unexpectedly, virus-cell binding was detected to a similar extent in
both the presence and the absence of specific receptor-Env interaction.
Virus binding in the absence of cognate Env contradicted previous
reports (5, 8, 19, 24) analyzing viral binding by using FACS
as well as the concept that Env-receptor interaction promotes virus
binding to cells. Comparison of FACS and microscopy observations of the
same samples (Fig. 5) demonstrated that FACS analysis detects the
binding of soluble SU proteins, shed from packaging cells or viral
particles (8), to specific receptors and therefore indicates
the levels of receptor on the cell surface. In contrast to microscopy
observations, however, FACS did not detect the binding of virions
bearing irrelevant Env (MLV-E on human cells). These results indicate
that virus binding on certain cell types does not require specific
Env-receptor interaction. Furthermore, comparison of MLV-A binding on
suspension cell cultures by FACS and microscopy observations (Fig. 9)
demonstrated that certain suspension cell lines can bind virus
particles only poorly, despite the presence of similar levels of the
MLV-A receptor Pit2 to those found on adherent cell lines. This result
suggests that the Env-receptor interaction is not sufficient for
efficient virion-cell binding and that such adsorption of the virus to
the cell is mediated by cell surface components other than the specific
virus receptor. The kinetics of virus binding on TE671 cells was
similarly rapid under both conditions, i.e., where cognate receptors
and Env are present and where virus bears no Env (Fig. 6). A time
course of virus-cell dissociation showed that virion-cell binding was
equally stable in the presence and absence of Env (Fig. 7). Therefore, specific Env-receptor interaction did not affect the kinetics of such
rapid, stable binding between virus particles and cells. Overall, these
results indicate that Env-receptor-independent binding could precede
the recognition of the cognate receptors by virus particles.
Nonspecific, viral receptor-independent binding of virus particles to
cell membranes has been observed for vesicular stomatitis virus
(34), and Rous sarcoma virus (30, 32). However,
the significance of such virus adsorption has been unclear. It is possible that viral particles first bind to the cell surface without the involvement of specific viral receptors and subsequently interact with their cognate receptors or functional virus entry sites in many
cases of MLV infection. Particles bound to the cell surface could
screen for the receptor molecules in two dimensions, while unbound
particles must seek their receptors in the three-dimensional space
moving with Brownian motion. We therefore suggest that
receptor-Env-independent binding of the virus to the cell plays an
important role by helping MLV particles to reach the specific receptor
and subsequently enter the cell. It is intriguing that the suspension
cell lines tested in this study have poor ability to adsorb virus
particles and are less infectible than adherent cell lines, which can
bind virus particles efficiently. This observation supports our
hypothesis that virus binding independent of specific Env-receptor
interaction enhances infection, although many other cellular components
may affect efficient infection at various stages in the process, such as provirus integration (11, 16).
The ability of MLV and other retroviruses to assemble components of
cellular origin in their envelope lipid bilayer is well documented
(42). It is therefore likely that one or more of these
components are responsible for the Env-independent binding and
subsequent enhancement of infection. This hypothesis is supported by
recent reports that HIV particles, which bear adhesion molecules and
therefore can bind to cells more efficiently in a CD4-independent manner, infect cells more efficiently than does HIV without such adhesion molecules (14, 31). In addition, binding and
internalization of HIV to cells lacking the binding receptor CD4 has
been described (23, 28, 39). Finally, some cellular
components, such as integrin molecules and proteoglycans, were
suggested to be involved in CD4-independent HIV binding. It is
presently unknown if any of these molecules can mediate the binding of
MLV particles; some CD4-independent binding of HIV also seems to
require HIV SU proteins under some circumstances (28, 39).
There is considerable interest in the development of targeted
retrovirus vectors for in vivo gene therapy. In several studies, specific ligands have been incorporated into vector envelopes to
retarget vectors to specific cell types or to enhance vector infection
of target cells, but without much success (9). Our finding
that retroviruses can bind to the cell in a manner independent of
Env-receptor interaction may be relevant to targeting. First, vector
particles may be wasted by binding to cells which lack targeted
receptors in in vivo settings. Second, incorporation of specific
ligands to the virus envelope may not necessarily result in significant
enhancement of binding of the vector particle to the target cell,
although such modifications can redirect Env proteins to cells bearing
their specific receptors, as shown by FACS assays for Env binding
(8, 24). Our results suggest the need for cautious
interpretations of FACS analyses and indicate that targeting of
retrovirus vectors at the later stages of vector infection, such as
virus-cell fusion rather than virus-cell binding, may be more effective.
In conclusion, we have established that single retrovirus particles can
be visualized by optical microscopy with immunofluorescent staining.
This method has further demonstrated that MLV particles can bind to
cells with rapid kinetics in a mechanism independent of specific
receptor-Env interaction.
 |
ACKNOWLEDGMENTS |
We are grateful to Robin Weiss and Áine McKnight for
critical reading of the manuscript and for helpful discussions. We
thank Hugh Paterson for helpful advice on confocal microscopy.
This work is supported by Glaxo-Wellcome and the Medical Research
Council. M.P. is funded by an EU TMR grant (no. FMBICT961804).
 |
FOOTNOTES |
*
Corresponding author. Present address: Windeyer
Institute of Medical Sciences, Wohl Virion Centre, University College
London, 46 Cleveland St., London W1P 6DB, United Kingdom. Phone: 44 171 504 9569. Fax: 44 171 504 9555. E-mail:
y.takeuchi{at}ucl.ac.uk.
Present address: Windeyer Institute of Medical Sciences, University
College London, London W1P 6DB, United Kingdom.
 |
REFERENCES |
| 1.
|
Allison, A. C., and R. C. Valentine.
1959.
Virus particle adsorption. I. Theory of adsorption and experiments on the attachment of particles to non-biological surfaces.
Biochim. Biophys. Acta
34:10-23[Medline].
|
| 2.
|
Allison, A. C., and R. C. Valentine.
1959.
Virus particle adsorption. II. Adsorption of vaccinia and fowl plaque viruses to cells in suspension.
Biochim. Biophys. Acta
40:393-399.
|
| 3.
|
Allison, A. C., and R. C. Valentine.
1959.
Virus particle adsorption. III. Adsorption of viruses by cell monolayers and effect of some variables on adsorption.
Biochim. Biophys. Acta.
40:400-410.
|
| 4.
|
Bartlett, J. S., and R. J. Samulski.
1998.
Fluorescent viral vectors: a new technique for the pharmacological analysis of gene therapy.
Nat. Med.
4:635-637[Medline].
|
| 5.
|
Battini, J. L.,
P. Rodrigues,
R. Muller,
O. Danos, and J. M. Heard.
1996.
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein.
J. Virol.
70:4387-4393[Abstract].
|
| 6.
|
Chillakuru, R. A.,
D. D. Ryu, and T. Yilma.
1991.
Propagation of recombinant vaccinia virus in HeLa cells: adsorption kinetics and replication in batch cultures.
Biotechnol. Prog.
7:85-92[Medline].
|
| 7.
|
Chuck, A. S.,
M. F. Clarke, and B. O. Palsson.
1996.
Retroviral infection is limited by Brownian motion.
Hum. Gene Ther.
7:1527-1534[Medline].
|
| 8.
|
Cosset, F. L.,
F. J. Morling,
Y. Takeuchi,
R. A. Weiss,
M. K. Collins, and S. J. Russell.
1995.
Retroviral retargeting by envelopes expressing an N-terminal binding domain.
J. Virol.
69:6314-6322[Abstract].
|
| 9.
|
Cosset, F. L., and S. J. Russell.
1996.
Targeting retrovirus entry.
Gene Ther.
3:946-956[Medline].
|
| 10.
|
Cosset, F. L.,
Y. Takeuchi,
J. L. Battini,
R. A. Weiss, and M. K. Collins.
1995.
High-titer packaging cells producing recombinant retroviruses resistant to human serum.
J. Virol.
69:7430-7436[Abstract].
|
| 11.
|
Daniel, R.,
R. A. Katz, and A. M. Skalka.
1999.
A role for DNA-PK in retroviral DNA integration.
Science
284:644-647[Abstract/Free Full Text].
|
| 12.
|
DeLarco, J., and G. J. Todaro.
1976.
Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71.
Cell
8:365-371[Medline].
|
| 13.
|
Evans, L. H.,
R. P. Morrison,
F. G. Malik,
J. Portis, and W. J. Britt.
1990.
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.
J. Virol.
64:6176-6183[Abstract/Free Full Text].
|
| 14.
|
Fortin, J. F.,
R. Cantin,
G. Lamontagne, and M. Tremblay.
1997.
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.
J. Virol.
71:3588-3596[Abstract].
|
| 15.
|
Frank, H.,
H. Schwarz,
T. Graf, and W. Schafer.
1978.
Properties of mouse leukemia viruses. XV. Electron microscopic studies on the organization of Friend leukemia virus and other mammalian C-type viruses.
Z Naturforsch Ser. C
33:124-138.
|
| 16.
|
Gaken, J. A.,
M. Tavassoli,
S. U. Gan,
S. Vallian,
I. Giddings,
D. C. Darling,
J. Galea-Lauri,
M. G. Thomas,
H. Abedi,
V. Schreiber,
J. Menissier-de Murcia,
M. K. Collins,
S. Shall, and F. Farzaneh.
1996.
Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.
J. Virol.
70:3992-4000[Abstract].
|
| 17.
|
Gallay, P.,
T. Hope,
D. Chin, and D. Trono.
1997.
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.
Proc. Natl. Acad. Sci. USA
94:9825-9830[Abstract/Free Full Text].
|
| 18.
|
Ganguly, K.,
V. S. Kalyanaraman, and M. G. Sarngadharan.
1983.
Analysis of the interaction between Rauscher murine leukemia virus and murine cell membrane receptor by in vitro binding assay.
Cancer Lett.
18:79-86[Medline].
|
| 19.
|
Kadan, M. J.,
S. Sturm,
W. F. Anderson, and M. A. Eglitis.
1992.
Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.
J. Virol.
66:2281-2287[Abstract/Free Full Text].
|
| 20.
|
Kimpton, J., and M. Emerman.
1992.
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated -galactosidase gene.
J. Virol.
66:2232-2239[Abstract/Free Full Text].
|
| 21.
|
Kozak, S. L.,
D. C. Siess,
M. P. Kavanaugh,
A. D. Miller, and D. Kabat.
1995.
The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species.
J. Virol.
69:3433-3440[Abstract].
|
| 22.
|
Leopold, P. L.,
B. Ferris,
I. Grinberg,
S. Worgall,
N. R. Hackett, and R. G. Crystal.
1998.
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells.
Hum. Gene Ther.
9:367-378[Medline].
|
| 23.
|
Marechal, V.,
F. Clavel,
J. M. Heard, and O. Schwartz.
1998.
Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1.
J. Virol.
72:2208-2212[Abstract/Free Full Text].
|
| 24.
|
Martin, F.,
J. Kupsch,
Y. Takeuchi,
S. Russell,
F. L. Cosset, and M. Collins.
1998.
Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.
Hum. Gene Ther.
9:737-746[Medline].
|
| 25.
|
McKeating, J. A.,
A. McKnight, and J. P. Moore.
1991.
Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
J. Virol.
65:852-860[Abstract/Free Full Text].
|
| 26.
|
McKnight, A.,
R. A. Weiss,
C. Shotton,
Y. Takeuchi,
H. Hoshino, and P. R. Clapham.
1995.
Change in tropism upon immune escape by human immunodeficiency virus.
J. Virol.
69:3167-3170[Abstract].
|
| 27.
|
Mittereder, N.,
K. L. March, and B. C. Trapnell.
1996.
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.
J. Virol.
70:7498-7509[Abstract].
|
| 28.
|
Mondor, I.,
S. Ugolini, and Q. J. Sattentau.
1998.
Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.
J. Virol.
72:3623-3634[Abstract/Free Full Text].
|
| 29.
|
Nermut, M. V.,
H. Frank, and W. Schafer.
1972.
Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching.
Virology
49:345-358[Medline].
|
| 30.
|
Notter, M. F.,
J. F. Leary, and P. C. Balduzzi.
1982.
Adsorption of Rous sarcoma virus to genetically susceptible and resistant chicken cells studied by laser flow cytometry.
J. Virol.
41:958-964[Abstract/Free Full Text].
|
| 31.
|
Paquette, J. S.,
J. F. Fortin,
L. Blanchard, and M. J. Tremblay.
1998.
Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.
J. Virol.
72:9329-9336[Abstract/Free Full Text].
|
| 32.
|
Piraino, F.
1967.
The mechanism of genetic resistance of chick embryo cells to infection by Rous sarcoma virus-BRYAN strain (BS-RSV).
Virology
32:700[Medline].
|
| 33.
|
Pudney, J., and M. J. Song.
1994.
Electron microscopic analysis of HIV-host cell interactions.
Tissue Cell
26:539-550[Medline].
|
| 34.
|
Schlegel, R.,
M. C. Willingham, and I. H. Pastan.
1982.
Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells.
J. Virol.
43:871-875[Abstract/Free Full Text].
|
| 35.
|
Smith, R. E.
1974.
High specific infectivity avian RNA tumor viruses.
Virology
60:543-547[Medline].
|
| 36.
|
Tailor, C. S.,
Y. Takeuchi,
B. O'Hara,
S. V. Johann,
R. A. Weiss, and M. K. Collins.
1993.
Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections.
J. Virol.
67:6737-6741[Abstract/Free Full Text].
|
| 37.
|
Takeuchi, Y.,
M. Akutsu,
K. Murayama,
N. Shimizu, and H. Hoshino.
1991.
Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.
J. Virol.
65:1710-1718[Abstract/Free Full Text].
|
| 38.
|
Tavoloni, N.
1997.
A simple procedure to determine the biological titer of recombinant retroviral vectors.
Gene Ther.
4:150-155[Medline].
|
| 39.
|
Valenzuela, A.,
J. Blanco,
B. Krust,
R. Franco, and A. G. Hovanessian.
1997.
Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
J. Virol.
71:8289-8298[Abstract].
|
| 40.
|
Vanderplasschen, A., and G. L. Smith.
1997.
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.
J. Virol.
71:4032-4041[Abstract].
|
| 41.
|
Wang, H.,
R. Paul,
R. E. Burgeson,
D. R. Keene, and D. Kabat.
1991.
Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor.
J. Virol.
65:6468-6477[Abstract/Free Full Text].
|
| 42.
|
Weiss, R. A.
1993.
Cellular receptor and viral glycoproteins involved in retrovirus entry, p. 1-108.
In
J. A. Levy (ed.), The Retroviridae, vol. 2. Plenum Press, New York, N.Y.
|
| 43.
|
Yu, H.,
C. Empig,
J. Xia, and W. F. Anderson.
1998.
Quantitation of MoMuLV envelope protein on the cell surface.
Virology
243:415-422[Medline].
|
| 44.
|
Yu, H.,
N. Soong, and W. F. Anderson.
1995.
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells.
J. Virol.
69:6557-6562[Abstract].
|
| 45.
|
Zheng, Y. Z.,
R. Webb,
P. F. Greenfield, and S. Reid.
1996.
Improved method for counting virus and virus like particles.
J. Virol. Methods
62:153-159[Medline].
|
Journal of Virology, October 1999, p. 8599-8611, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ryu, B. Y., Zavorotinskaya, T., Trentin, B., Albritton, L. M.
(2008). The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteins. J. Gen. Virol.
89: 1049-1058
[Abstract]
[Full Text]
-
Segura, M. M., Garnier, A., Di Falco, M. R., Whissell, G., Meneses-Acosta, A., Arcand, N., Kamen, A.
(2008). Identification of Host Proteins Associated with Retroviral Vector Particles by Proteomic Analysis of Highly Purified Vector Preparations. J. Virol.
82: 1107-1117
[Abstract]
[Full Text]
-
Beer, C., Pedersen, L.
(2007). Matrix Fibronectin Binds Gammaretrovirus and Assists in Entry: New Light on Viral Infections. J. Virol.
81: 8247-8257
[Abstract]
[Full Text]
-
Ciczora, Y., Callens, N., Penin, F., Pecheur, E.-I., Dubuisson, J.
(2007). Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus Entry. J. Virol.
81: 2372-2381
[Abstract]
[Full Text]
-
Pan, Y.-W., Scarlett, J. M., Luoh, T. T., Kurre, P.
(2007). Prolonged Adherence of Human Immunodeficiency Virus-Derived Vector Particles to Hematopoietic Target Cells Leads to Secondary Transduction In Vitro and In Vivo. J. Virol.
81: 639-649
[Abstract]
[Full Text]
-
Wallin, M., Loving, R., Ekstrom, M., Li, K., Garoff, H.
(2005). Kinetic Analyses of the Surface-Transmembrane Disulfide Bond Isomerization-Controlled Fusion Activation Pathway in Moloney Murine Leukemia Virus. J. Virol.
79: 13856-13864
[Abstract]
[Full Text]
-
Beer, C., Andersen, D. S., Rojek, A., Pedersen, L.
(2005). Caveola-Dependent Endocytic Entry of Amphotropic Murine Leukemia Virus. J. Virol.
79: 10776-10787
[Abstract]
[Full Text]
-
Wallin, M., Ekstrom, M., Garoff, H.
(2005). The Fusion-Controlling Disulfide Bond Isomerase in Retrovirus Env Is Triggered by Protein Destabilization. J. Virol.
79: 1678-1685
[Abstract]
[Full Text]
-
Lavillette, D., Kabat, D.
(2004). Porcine Endogenous Retroviruses Infect Cells Lacking Cognate Receptors by an Alternative Pathway: Implications for Retrovirus Evolution and Xenotransplantation. J. Virol.
78: 8868-8877
[Abstract]
[Full Text]
-
Magre, S., Takeuchi, Y., Langford, G., Richards, A., Patience, C., Weiss, R.
(2004). Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-{alpha}(1-3) Galactosyl Epitope. J. Virol.
78: 5812-5819
[Abstract]
[Full Text]
-
Davis, H. E., Rosinski, M., Morgan, J. R., Yarmush, M. L.
(2004). Charged Polymers Modulate Retrovirus Transduction via Membrane Charge Neutralization and Virus Aggregation. Biophys. J
86: 1234-1242
[Abstract]
[Full Text]
-
Burrer, R., Haessig-Einius, S., Aubertin, A.-M., Moog, C.
(2003). Polyclonal Immunoglobulin G from Patients Neutralizes Human Immunodeficiency Virus Type 1 Primary Isolates by Binding Free Virions, but without Interfering with an Initial CD4-Independent Attachment of the Virus to Primary Blood Mononuclear Cells. J. Virol.
77: 11385-11397
[Abstract]
[Full Text]
-
Andrawiss, M., Takeuchi, Y., Hewlett, L., Collins, M.
(2003). Murine Leukemia Virus Particle Assembly Quantitated by Fluorescence Microscopy: Role of Gag-Gag Interactions and Membrane Association. J. Virol.
77: 11651-11660
[Abstract]
[Full Text]
-
Gould, S. J., Booth, A. M., Hildreth, J. E. K.
(2003). The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA
100: 10592-10597
[Abstract]
[Full Text]
-
Spitzer, D., Dittmar, K. E. J., Rohde, M., Hauser, H., Wirth, D.
(2003). Green Fluorescent Protein-Tagged Retroviral Envelope Protein for Analysis of Virus-Cell Interactions. J. Virol.
77: 6070-6075
[Abstract]
[Full Text]
-
Lavillette, D., Ruggieri, A., Boson, B., Maurice, M., Cosset, F.-L.
(2002). Relationship between SU Subdomains That Regulate the Receptor-Mediated Transition from the Native (Fusion-Inhibited) to the Fusion-Active Conformation of the Murine Leukemia Virus Glycoprotein. J. Virol.
76: 9673-9685
[Abstract]
[Full Text]
-
Sandrin, V., Boson, B., Salmon, P., Gay, W., Negre, D., Le Grand, R., Trono, D., Cosset, F.-L.
(2002). Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood
100: 823-832
[Abstract]
[Full Text]
-
Walker, S. J., Pizzato, M., Takeuchi, Y., Devereux, S.
(2002). Heparin Binds to Murine Leukemia Virus and Inhibits Env-Independent Attachment and Infection. J. Virol.
76: 6909-6918
[Abstract]
[Full Text]
-
Knauss, D. J., Young, J. A. T.
(2002). A Fifteen-Amino-Acid TVB Peptide Serves as a Minimal Soluble Receptor for Subgroup B Avian Leukosis and Sarcoma Viruses. J. Virol.
76: 5404-5410
[Abstract]
[Full Text]
-
Towers, G., Collins, M., Takeuchi, Y.
(2002). Abrogation of Ref1 Retrovirus Restriction in Human Cells. J. Virol.
76: 2548-2550
[Abstract]
[Full Text]
-
Jinno-Oue, A., Oue, M., Ruscetti, S. K.
(2001). A Unique Heparin-Binding Domain in the Envelope Protein of the Neuropathogenic PVC-211 Murine Leukemia Virus May Contribute to Its Brain Capillary Endothelial Cell Tropism. J. Virol.
75: 12439-12445
[Abstract]
[Full Text]
-
Techaarpornkul, S., Barretto, N., Peeples, M. E.
(2001). Functional Analysis of Recombinant Respiratory Syncytial Virus Deletion Mutants Lacking the Small Hydrophobic and/or Attachment Glycoprotein Gene. J. Virol.
75: 6825-6834
[Abstract]
[Full Text]
-
Sharma, S., Miyanohara, A., Friedmann, T.
(2000). Separable Mechanisms of Attachment and Cell Uptake during Retrovirus Infection. J. Virol.
74: 10790-10795
[Abstract]
[Full Text]
-
Bachrach, E., Marin, M., Pelegrin, M., Karavanas, G., Piechaczyk, M.
(2000). Efficient Cell Infection by Moloney Murine Leukemia Virus-Derived Particles Requires Minimal Amounts of Envelope Glycoprotein. J. Virol.
74: 8480-8486
[Abstract]
[Full Text]
-
Olinger, G. G., Saifuddin, M., Spear, G. T.
(2000). CD4-Negative Cells Bind Human Immunodeficiency Virus Type 1 and Efficiently Transfer Virus to T Cells. J. Virol.
74: 8550-8557
[Abstract]
[Full Text]
-
Hammarstedt, M., Wallengren, K., Pedersen, K. W., Roos, N., Garoff, H.
(2000). Minimal exclusion of plasma membrane proteins during retroviral envelope formation. Proc. Natl. Acad. Sci. USA
10.1073/pnas.120051597v1
[Abstract]
[Full Text]
-
Lavillette, D., Ruggieri, A., Russell, S. J., Cosset, F.-L.
(2000). Activation of a Cell Entry Pathway Common to Type C Mammalian Retroviruses by Soluble Envelope Fragments. J. Virol.
74: 295-304
[Abstract]
[Full Text]
-
Hammarstedt, M., Wallengren, K., Pedersen, K. W., Roos, N., Garoff, H.
(2000). Minimal exclusion of plasma membrane proteins during retroviral envelope formation. Proc. Natl. Acad. Sci. USA
97: 7527-7532
[Abstract]
[Full Text]